Search images on Google      Product Monograph

Active Ingredients:

• bortezomib (bortezomib mannitol boronic ester), 3.5 MG/VIAL

DIN: 02438399

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS, SUBCUTANEOUS

Description: SINGLE-USE VIAL

Schedule: Prescription

Company: TEVA CANADA LIMITED  –  official site

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01X - OTHER ANTINEOPLASTIC AGENTS (ATC, WHO)
• L01XG - (ATC, WHO)
• L01XG01 - BORTEZOMIB (WHO)

 

External Links for Act Bortezomib:

Search on Google

• Act Bortezomib side effects
• Act Bortezomib dosage
• bortezomib side effects
• bortezomib dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find act bortezomib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.